Clinical Trials Browser

Unknown × INDUSTRY × napabucasin × Clear all

NCT03522649 2019-06-18

A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Previously Treated Metastatic Colorectal Cancer